Poseida Therapeutics Inc [PSTX] stock prices are up 227.97% to $9.38 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The PSTX shares have gain 238.63% over the last week, with a monthly amount glided 278.23%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Poseida Therapeutics Inc [NASDAQ: PSTX] stock has seen the most recent analyst activity on January 04, 2023, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $15. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on January 07, 2022, and set its price target to $24. On May 18, 2021, BTIG Research initiated with a Buy rating and assigned a price target of $40 on the stock. William Blair started tracking the stock assigning a Outperform rating. Piper Sandler initiated its recommendation with a Overweight and recommended $30 as its price target on August 04, 2020. BofA Securities started tracking with a Buy rating for this stock on August 04, 2020, and assigned it a price target of $20.
The stock price of Poseida Therapeutics Inc [PSTX] has been fluctuating between $1.87 and $4.27 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Poseida Therapeutics Inc [NASDAQ: PSTX] shares were valued at $9.38 at the most recent close of the market. An investor can expect a potential return of 59.91% based on the average PSTX price forecast.
Analyzing the PSTX fundamentals
The Poseida Therapeutics Inc [NASDAQ:PSTX] reported sales of 150.86M for trailing twelve months, representing a surge of 667.19%. Gross Profit Margin for this corporation currently stands at 0.95% with Operating Profit Margin at -0.41%, Pretax Profit Margin comes in at -0.4%, and Net Profit Margin reading is -0.39%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.71 and Total Capital is -0.29. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.28 points at the first support level, and at 9.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.44, and for the 2nd resistance point, it is at 9.51.
Ratios To Look Out For
It’s worth pointing out that Poseida Therapeutics Inc [NASDAQ:PSTX]’s Current Ratio is 3.20. On the other hand, the Quick Ratio is 3.20, and the Cash Ratio is 0.63. Considering the valuation of this stock, the price to sales ratio is 6.06, the price to book ratio is 10.48.
Transactions by insiders
Recent insider trading involved MARK GERGEN, Director, that happened on Nov 26 ’24 when 0.12 million shares were purchased.
